Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Apr;12(1-2):12-6.
doi: 10.1007/BF01965099.

Concentration effect relationships of infused histamine in normal volunteers

Concentration effect relationships of infused histamine in normal volunteers

P W Ind et al. Agents Actions. 1982 Apr.

Abstract

Histamine was infused in six normal volunteers at rates of 16, 32, 64 and 96 ng/kg/min increasing at 5-min intervals followed by 128 ng/kg/min for 45 min. Heart rate increased, diastolic blood pressure decreased and skin temperature increased in a dose-dependent fashion. Mean heart rate increased by 15.6 +/- 5.7 beats/min, mean diastolic pressure fell by 8.8 +/- e.2 mmHg and mean skin temperature increased by 1.2 +/- 0.3 degrees C at the highest infusion rate. Mean plasma histamine rose from a basal level of 0.20 +/- 0.03 ng/ml to 1.97 +/- 0.25 ng/ml at the end of the highest infusion rate. The threshold infusion rate for physiological effects was 64-96 ng/kg/min corresponding to 0.77-0.97 ng/ml. Salivary flow was stimulated by 21% after 30 min at the highest dose infusion (P = 0.05). Plasma adrenaline increased 132% but plasma noradrenaline was unchanged. There was a linear decline in heart rate after terminating the histamine infusion with a half time of 82 sec. The half life of infused histamine in the plasma was 102 sec. The clearance of histamine from the plasma was 6.1 %/- 0.2 l/min or 83 ml/kg/min. These concentration effect relationships in normals throw doubt on some of the high endogenous plasma histamine values in the literature.

PubMed Disclaimer

References

    1. Agents Actions. 1980 Apr;10(1 Pt 2):114-24 - PubMed
    1. J Clin Invest. 1980 Jul;66(1):94-101 - PubMed
    1. Clin Sci (Lond). 1979 Jul;57(1):39-45 - PubMed
    1. Mt Sinai J Med. 1978 May-Jun;45(3):357-86 - PubMed
    1. J Allergy Clin Immunol. 1980 Oct;66(4):295-8 - PubMed

Publication types